NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesMontserrat García‐Closas, Nathaniel Rothman, Manolis Kogevinas et al.|The Lancet|2005Cited by 631
Benzene and the Dose-Related Incidence of Hematologic Neoplasms in ChinaRichard B. Hayes, Chung‐Yi Li, Mustafa Dosemeci et al.|JNCI Journal of the National Cancer Institute|1997Cited by 343